Brainstorm Cell Therapeutics Stock Price on December 1, 2024
BCLI Stock | USD 1.74 0.12 7.41% |
If you're considering investing in Brainstorm Stock, it is important to understand the factors that can impact its price. As of today, the current price of Brainstorm Cell stands at 1.74, as last reported on the 2nd of December, with the highest price reaching 1.84 and the lowest price hitting 1.70 during the day. Brainstorm Cell Ther secures Sharpe Ratio (or Efficiency) of -0.2, which signifies that the company had a -0.2% return per unit of standard deviation over the last 3 months. Brainstorm Cell Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Brainstorm Cell's mean deviation of 4.47, and Risk Adjusted Performance of (0.15) to double-check the risk estimate we provide.
Brainstorm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Brainstorm |
Sharpe Ratio = -0.2037
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | BCLI |
Estimated Market Risk
6.11 actual daily | 54 54% of assets are less volatile |
Expected Return
-1.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Brainstorm Cell is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Brainstorm Cell by adding Brainstorm Cell to a well-diversified portfolio.
Related Headline
Cue Biopharma Headline on 29th of November 2024
Cue BiopharmaReports Inducement Grant Under Nasdaq Listing R... by finance.yahoo.com
BOSTON, Mass., Nov. 29, 2024 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today announced the grant of an inducement option award to its newly appointed interim chief development officer, Daniel Baker, M.D. The grant was approved by a majority of the independent directors of the Compa
Brainstorm Cell Valuation on December 1, 2024
It is possible to determine the worth of Brainstorm Cell on a given historical date. On December 1, 2024 Brainstorm was worth 1.73 at the beginning of the trading date compared to the closed value of 1.74. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Brainstorm Cell stock. Still, in general, we apply an absolute valuation method to find Brainstorm Cell's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Brainstorm Cell where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Brainstorm Cell's related companies.
Open | High | Low | Close | Volume | |
1.62 | 1.82 | 1.62 | 1.74 | 150,996 | |
11/29/2024 | 1.73 | 1.84 | 1.70 | 1.74 | 78,671 |
1.73 | 1.84 | 1.70 | 1.74 | 0.00 |
Backtest Brainstorm Cell | | | Brainstorm Cell History | | | Brainstorm Cell Valuation | Previous | Next |
Brainstorm Cell Trading Date Momentum on December 1, 2024
On December 02 2024 Brainstorm Cell Therapeutics was traded for 1.74 at the closing time. The top price for the day was 1.84 and the lowest listed price was 1.70 . There was no trading activity during the period 0.0. Lack of trading volume on December 2, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.57% . |
Brainstorm Cell Ther Fundamentals Correlations and Trends
By evaluating Brainstorm Cell's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Brainstorm Cell's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Brainstorm financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Brainstorm Cell Stock history
Brainstorm Cell investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Brainstorm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Brainstorm Cell Ther will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Brainstorm Cell stock prices may prove useful in developing a viable investing in Brainstorm Cell
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York. Brainstorm Cell operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.
Brainstorm Cell Stock Technical Analysis
Brainstorm Cell technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Brainstorm Cell Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Brainstorm Cell Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Brainstorm Cell December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Brainstorm Cell stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Brainstorm Cell shares will generate the highest return on investment. By undertsting and applying Brainstorm Cell stock market strength indicators, traders can identify Brainstorm Cell Therapeutics entry and exit signals to maximize returns
Brainstorm Cell Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Brainstorm Cell's price direction in advance. Along with the technical and fundamental analysis of Brainstorm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Brainstorm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.15) | |||
Jensen Alpha | (1.28) | |||
Total Risk Alpha | (2.27) | |||
Treynor Ratio | (5.41) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Brainstorm Stock analysis
When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Transaction History View history of all your transactions and understand their impact on performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |